Global Custom Peptide CDMO Services Market Growth (Status and Outlook) 2024-2030

Global Custom Peptide CDMO Services Market Growth (Status and Outlook) 2024-2030

Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.

The global Custom Peptide CDMO Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Custom Peptide CDMO Services Industry Forecast” looks at past sales and reviews total world Custom Peptide CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Peptide CDMO Services sales for 2023 through 2029. With Custom Peptide CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Peptide CDMO Services industry.

This Insight Report provides a comprehensive analysis of the global Custom Peptide CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Peptide CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Peptide CDMO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Peptide CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Peptide CDMO Services.

United States market for Custom Peptide CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Custom Peptide CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Custom Peptide CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Custom Peptide CDMO Services players cover Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Peptide CDMO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
GMP Services
Non-GMP Services

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
GMP Services
Non-GMP Services

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem

Please note: The report will take approximately 2 business days to prepare and deliver.